171 related articles for article (PubMed ID: 5509665)
1. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
[No Abstract] [Full Text] [Related]
2. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
Bergström J; Bergquist-Poppen M; Bucht H
Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
[No Abstract] [Full Text] [Related]
3. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
Caparello O; Contino A; Viola A; Pirro G
Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
[No Abstract] [Full Text] [Related]
4. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
Haan D
Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
[No Abstract] [Full Text] [Related]
5. [Clinical experiences with a new antihypertensive agent].
Lieb W; Ridders K
Arzneimittelforschung; 1966 Dec; 16(12):1610-5. PubMed ID: 6014793
[No Abstract] [Full Text] [Related]
6. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
Vettore L
Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
[No Abstract] [Full Text] [Related]
7. [Catapresan--a new hypotensive agent].
Tarkowska A
Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
[No Abstract] [Full Text] [Related]
8. [On the therapy of hypertension with an imidazoline derivative].
Krause W; Krämer D; Grünitz B
Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
[No Abstract] [Full Text] [Related]
9. [French experience with Clonidine].
Nouv Presse Med; 1972 Mar; 1(13):877-82. PubMed ID: 4622968
[No Abstract] [Full Text] [Related]
10. [Controllable hypertension therapy with Tadip].
Schütz E
Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
Kotzaurek R; Schmidt P; Widhalm F
Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
[No Abstract] [Full Text] [Related]
12. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
Palagi L; D'Elia M; Lanzara P; Criscione SM
Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
[No Abstract] [Full Text] [Related]
13. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
Langer-Costanzi M
Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
[No Abstract] [Full Text] [Related]
14. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
Krämer D; Krause W; Renner H
Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
[No Abstract] [Full Text] [Related]
15. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
Fritsch H; Bachmann GW; Lenhard J
Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
[No Abstract] [Full Text] [Related]
16. [Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline].
Bock KD; Heimsoth V; Merguet P; Schönermark J
Dtsch Med Wochenschr; 1966 Oct; 91(40):1761-70. PubMed ID: 5922724
[No Abstract] [Full Text] [Related]
17. [Medico-social aspects of arterial hypertension and clinical considerations on its treatment with the guanoxane-polythiazide combination].
Di Benedetto A; Di Blasi S
Minerva Med; 1967 Mar; 58(21):893-6. PubMed ID: 6026542
[No Abstract] [Full Text] [Related]
18. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
Curri G
Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
[No Abstract] [Full Text] [Related]
19. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
Montagnani M; Bayelli PF; Antonelli A; Barducci O
Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
[No Abstract] [Full Text] [Related]
20. [Report on experiences with the drug Haemiton].
Müller D
Dtsch Gesundheitsw; 1970 Aug; 25(32):1517. PubMed ID: 5509391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
